Germany · Question · Schriftliche Frage
19/19021
Knowledge of disrupted supply chains in the pharmaceutical industry due to export restrictions
Introduced
7 May 2020
Last action
—
Status
Beantwortet
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
Original text of the question(s):<br /> <br /> Does the Federal Government have information on disrupted supply chains in the pharmaceutical industry due to the export restrictions according to the implementing regulations (EU) 2020/402, (EU) 2020/426, (EU) 2020/568 and in connection with the requirements of industrial cleanroom production due to the export restrictions according to (EU) 2020/402, (EU) 2020/426, (EU) 2020/568, and if so, which ones?
Machine translation from German. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.